SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filings

Filing date Form Description Filing Group View
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
View HTML
8-K/A

Amendment to a previously filed 8-K

Current Reports
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML
8-K

Report of unscheduled material events or corporate event

Current Reports
View HTML

Data provided by Kaleidoscope.